Data I/O Corporation has signed a definitive agreement to acquire V-TEK, a semiconductor handling and packaging manufacturer, and A&J Programming, a device programming service provider, for approximately $23 million. The purchase will be paid partly in cash and partly in Data I/O common stock, totaling about 1.12 million shares. This acquisition aims to enhance Data I/O's offerings in semiconductor programming and security provisioning, supporting its growth in the electronics supply chain. The deal is expected to close soon, funded by cash on hand, stock issuance, and proceeds from a recent securities offering.
The news about Data I/O Corporation's acquisition agreement provides context for readers interested in semiconductor-related developments. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 19, 2026 18:31 WIB: out of 150 priced US stocks, 101 rose and 36 fell. Notable movers include BTDR (Bitdeer Technologies Group) at USD 8.09 with a 4.79% increase and a typical hold time of 16 days, CRSR (Corsair Gaming Inc) at USD 13.40 with a 4.77% increase and a typical hold time of 25 days, and ENTG (Entegris Inc) at USD 144.84 with a 4.40% increase and a typical hold time of 41 days.
Bill Gross, a serial entrepreneur behind over 175 companies, has launched Idealab.ai, a platform using AI to generate and share over 1.2 million business ideas based on real-world problems. The platform aims to lower barriers to entrepreneurship by h...
The Portnoy Law Firm has launched an investigation into Cardinal Infrastructure Group for possible securities fraud following the company's Q2 2026 financial report. Cardinal revealed a decline in its gross profit margin to 10.8%, down from 13.9% the...
AIOS Tech Inc. announced an agreement to acquire SmartCore Holdings Limited in an all-stock transaction valued at approximately $100 million. The deal will issue 33.3 million AIOS shares to SmartCore's sellers, who will hold about 80% of AIOS shares ...
XBiotech announced positive results from the Phase II TASKIN trial, where their antibody vilamakitug combined with standard chemotherapy improved 12-month overall survival to 61.3% in refractory metastatic colorectal cancer patients, surpassing the s...
Proof and Circle Internet Group demonstrated a new system where AI agents can prove the identity of the person they represent using Proof's x401 open identity protocol and pay merchants in USDC via Circle's x402 payment protocol. This innovation addr...
